Complement activation-related pathophysiological changes in anesthetized rats: Activator-dependent variations of symptoms and mediators of pseudoallergy

László Dézsi, T. Mészáros, Erik Orfi, Tamás G. Fülöp, Mark Hennies, L. Rosivall, P. Hamar, J. Szebeni, G. Szénási

Research output: Contribution to journalArticle

Abstract

Complement (C) activation can underlie the infusion reactions to liposomes and other nanoparticle-based medicines, a hypersensitivity syndrome that can be partially reproduced in animal models. However, the sensitivities and manifestations substantially differ in different species, and C activation may not be the only cause of pathophysiological changes. In order to map the species variation of C-dependent and -independent pseudoallergy (CARPA/CIPA), here we used known C activators and C activator liposomes to compare their acute hemodynamic, hematological, and biochemical effects in rats. These C activators were cobra venom factor (CVF), zymosan, AmBisome (at 2 doses), its amphotericin B-free vehicle (AmBisombo), and a PEGylated cholesterol-containing liposome (PEG-2000-chol), all having different powers to activate C in rat blood. The pathophysiological endpoints measured were blood pressure, leukocyte and platelet counts, and plasma thromboxane B2, while C activation was assessed by C3 consumption using the Pan-Specific C3 assay. The results showed strong linear correlation between C activation and systemic hypotension, pointing to a causal role of C activation in the hemodynamic changes. The observed thrombocytopenia and leukopenia followed by leukocytosis also correlated with C3 conversion in case of C activators, but not necessarily with C activation by liposomes. These findings are consistent with the double hit hypothesis of hypersensitivity reactions (HSRs), inasmuch as strong C activation can fully account for all symptoms of HSRs, but in case of no-, or weak C activators, the pathophysiological response, if any, is likely to involve other activation pathways.

Original languageEnglish
Article number3283
JournalMolecules
Volume24
Issue number18
DOIs
Publication statusPublished - Sep 9 2019

Fingerprint

Complement Activation
Liposomes
complement
rats
Rats
Chemical activation
activation
Hypersensitivity
Hemodynamics
Thromboxane B2
hemodynamics
Zymosan
Leukocytosis
Leukopenia
Amphotericin B
Platelet Count
Leukocyte Count
Thrombocytopenia
Hypotension
Nanoparticles

Keywords

  • Amphotericin B
  • Blood cell count
  • Blood pressure
  • Cobra venom factor
  • Complement activation
  • Infusion reactions
  • Thromboxane
  • Zymosan

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Complement activation-related pathophysiological changes in anesthetized rats : Activator-dependent variations of symptoms and mediators of pseudoallergy. / Dézsi, László; Mészáros, T.; Orfi, Erik; Fülöp, Tamás G.; Hennies, Mark; Rosivall, L.; Hamar, P.; Szebeni, J.; Szénási, G.

In: Molecules, Vol. 24, No. 18, 3283, 09.09.2019.

Research output: Contribution to journalArticle

@article{ebc4d6564a0f4d9f8d093f1bfb963aa7,
title = "Complement activation-related pathophysiological changes in anesthetized rats: Activator-dependent variations of symptoms and mediators of pseudoallergy",
abstract = "Complement (C) activation can underlie the infusion reactions to liposomes and other nanoparticle-based medicines, a hypersensitivity syndrome that can be partially reproduced in animal models. However, the sensitivities and manifestations substantially differ in different species, and C activation may not be the only cause of pathophysiological changes. In order to map the species variation of C-dependent and -independent pseudoallergy (CARPA/CIPA), here we used known C activators and C activator liposomes to compare their acute hemodynamic, hematological, and biochemical effects in rats. These C activators were cobra venom factor (CVF), zymosan, AmBisome (at 2 doses), its amphotericin B-free vehicle (AmBisombo), and a PEGylated cholesterol-containing liposome (PEG-2000-chol), all having different powers to activate C in rat blood. The pathophysiological endpoints measured were blood pressure, leukocyte and platelet counts, and plasma thromboxane B2, while C activation was assessed by C3 consumption using the Pan-Specific C3 assay. The results showed strong linear correlation between C activation and systemic hypotension, pointing to a causal role of C activation in the hemodynamic changes. The observed thrombocytopenia and leukopenia followed by leukocytosis also correlated with C3 conversion in case of C activators, but not necessarily with C activation by liposomes. These findings are consistent with the double hit hypothesis of hypersensitivity reactions (HSRs), inasmuch as strong C activation can fully account for all symptoms of HSRs, but in case of no-, or weak C activators, the pathophysiological response, if any, is likely to involve other activation pathways.",
keywords = "Amphotericin B, Blood cell count, Blood pressure, Cobra venom factor, Complement activation, Infusion reactions, Thromboxane, Zymosan",
author = "L{\'a}szl{\'o} D{\'e}zsi and T. M{\'e}sz{\'a}ros and Erik Orfi and F{\"u}l{\"o}p, {Tam{\'a}s G.} and Mark Hennies and L. Rosivall and P. Hamar and J. Szebeni and G. Sz{\'e}n{\'a}si",
year = "2019",
month = "9",
day = "9",
doi = "10.3390/molecules24183283",
language = "English",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "18",

}

TY - JOUR

T1 - Complement activation-related pathophysiological changes in anesthetized rats

T2 - Activator-dependent variations of symptoms and mediators of pseudoallergy

AU - Dézsi, László

AU - Mészáros, T.

AU - Orfi, Erik

AU - Fülöp, Tamás G.

AU - Hennies, Mark

AU - Rosivall, L.

AU - Hamar, P.

AU - Szebeni, J.

AU - Szénási, G.

PY - 2019/9/9

Y1 - 2019/9/9

N2 - Complement (C) activation can underlie the infusion reactions to liposomes and other nanoparticle-based medicines, a hypersensitivity syndrome that can be partially reproduced in animal models. However, the sensitivities and manifestations substantially differ in different species, and C activation may not be the only cause of pathophysiological changes. In order to map the species variation of C-dependent and -independent pseudoallergy (CARPA/CIPA), here we used known C activators and C activator liposomes to compare their acute hemodynamic, hematological, and biochemical effects in rats. These C activators were cobra venom factor (CVF), zymosan, AmBisome (at 2 doses), its amphotericin B-free vehicle (AmBisombo), and a PEGylated cholesterol-containing liposome (PEG-2000-chol), all having different powers to activate C in rat blood. The pathophysiological endpoints measured were blood pressure, leukocyte and platelet counts, and plasma thromboxane B2, while C activation was assessed by C3 consumption using the Pan-Specific C3 assay. The results showed strong linear correlation between C activation and systemic hypotension, pointing to a causal role of C activation in the hemodynamic changes. The observed thrombocytopenia and leukopenia followed by leukocytosis also correlated with C3 conversion in case of C activators, but not necessarily with C activation by liposomes. These findings are consistent with the double hit hypothesis of hypersensitivity reactions (HSRs), inasmuch as strong C activation can fully account for all symptoms of HSRs, but in case of no-, or weak C activators, the pathophysiological response, if any, is likely to involve other activation pathways.

AB - Complement (C) activation can underlie the infusion reactions to liposomes and other nanoparticle-based medicines, a hypersensitivity syndrome that can be partially reproduced in animal models. However, the sensitivities and manifestations substantially differ in different species, and C activation may not be the only cause of pathophysiological changes. In order to map the species variation of C-dependent and -independent pseudoallergy (CARPA/CIPA), here we used known C activators and C activator liposomes to compare their acute hemodynamic, hematological, and biochemical effects in rats. These C activators were cobra venom factor (CVF), zymosan, AmBisome (at 2 doses), its amphotericin B-free vehicle (AmBisombo), and a PEGylated cholesterol-containing liposome (PEG-2000-chol), all having different powers to activate C in rat blood. The pathophysiological endpoints measured were blood pressure, leukocyte and platelet counts, and plasma thromboxane B2, while C activation was assessed by C3 consumption using the Pan-Specific C3 assay. The results showed strong linear correlation between C activation and systemic hypotension, pointing to a causal role of C activation in the hemodynamic changes. The observed thrombocytopenia and leukopenia followed by leukocytosis also correlated with C3 conversion in case of C activators, but not necessarily with C activation by liposomes. These findings are consistent with the double hit hypothesis of hypersensitivity reactions (HSRs), inasmuch as strong C activation can fully account for all symptoms of HSRs, but in case of no-, or weak C activators, the pathophysiological response, if any, is likely to involve other activation pathways.

KW - Amphotericin B

KW - Blood cell count

KW - Blood pressure

KW - Cobra venom factor

KW - Complement activation

KW - Infusion reactions

KW - Thromboxane

KW - Zymosan

UR - http://www.scopus.com/inward/record.url?scp=85071929352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071929352&partnerID=8YFLogxK

U2 - 10.3390/molecules24183283

DO - 10.3390/molecules24183283

M3 - Article

C2 - 31505853

AN - SCOPUS:85071929352

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 18

M1 - 3283

ER -